Emine Çinici

Emine Çinici

Auto-generated profile, based on publicly available information

Emine Çinici

Department of Ophthalmology, Atatürk University Faculty of Medicine, Erzurum, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ECEmine Cinici
Emine Cinici
OCOzge Caglar
Ozge Caglar
MAMehmet Enes Arslan
Mehmet Enes Arslan
NDNilay Dilekmen
Nilay Dilekmen
BUBAHADIR UTLU
BAHADIR UTLU
Hasan TurkezHasan Turkez
Hasan Turkez
Age‐related macular degeneration (AMD) is an eye disease that impairs the sharp and central vision need for daily activities. Recent advances in molecular biology research not only lead to a better understanding of the genetics and pathophysiology of AMD but also to the development of applications based on targeted gene expressions to treat the disease. Clarification of molecular pathways that causing to development and progression in dry and wet types of AMD needs comprehensive and comparative investigations in particular precious biopsies involving peripheral blood samples from the patients. Therefore, in this investigation, dry and wet types of AMD patients and healthy individuals were aimed at investigating in regard to targeted gene candidates by using gene expression analysis for the first time. 13 most potent candidate genes involved in neurodegeneration were selected via in silico approach and investigated through gene expression analysis to suggest new targets for disease therapy. For the analyses, 30 individuals (10 dry and 10 wet types AMD patients and 10 healthy people) were involved in the study. SYBR‐Green based Real‐Time PCR analysis was performed on isolated peripheral blood mononuclear cells (PBMCs) to analyze differentially expressed genes related to these cases. According to the investigations, only the CRP gene was found to be upregulated for both dry and wet disease types. When the downregulated genes were analyzed, it was found that 11 genes were commonly decreased for both dry and wet types in the aspect of expression pattern. From these genes, CFH, CX3CR1, FLT1, and TIMP3 were found to have the most downregulated gene expression properties for both diseases. From these results, it might be concluded that these common upregulated and downregulated genes could be used as targets for early diagnosis and treatment for AMD.

25 October 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
EKEzgi Karatas
Ezgi Karatas
BYBulent Yavuzer
Bulent Yavuzer
ODOzlem Demir
Ozlem Demir
ESEsra Tuba Sezgin
Esra Tuba Sezgin
EHEngin Hendem
Engin Hendem
HSHalis Suleyman
Halis Suleyman
Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) such as erlotinib are widely used in non-small-cell lung cancer treatment, and accumulating evidence indicates they can markedly increase ocular toxicity. Nonetheless, whether erlotinib causes optic nerve injury has not been investigated before and remains a subject worth investigating. This study aimed to examine the impact of erlotinib on oxidative stress, inflammation, and histopathological changes in rat optic nerve tissue and evaluate the potential neuroprotective role of thiamine pyrophosphate (TPP). Methods: Twenty-four male Wistar rats were randomly assigned to four groups: healthy control, TPP alone, erlotinib alone, and erlotinib + TPP. Erlotinib (10 mg/kg, orally, on alternate days) and TPP (20 mg/kg, intraperitoneally, daily) were administered for two consecutive weeks. Optic nerve samples were analyzed for malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), catalase (CAT), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α), followed by histopathological examination. Results: Erlotinib treatment significantly increased MDA, IL-1β, and TNF-α levels while reducing tGSH, SOD, and CAT activity, demonstrating oxidative stress and an inflammatory response. Co-administration of TPP ameliorated these changes by lowering reactive oxygen species, restoring antioxidant capacity, and attenuating inflammation. Histopathological alterations, including astrocyte degeneration, edema, and vascular congestion, were evident after erlotinib exposure but were significantly alleviated when TPP was administered concurrently. Conclusions: Erlotinib induces oxidative and inflammatory optic nerve injury, while TPP co-treatment offers significant neuroprotection. These findings support TPP as a potential adjunct to reduce EGFR-TKI-related ocular toxicity and highlight importance of redox modulation in limiting treatment-associated side effects.

27 August 2025 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
BÇBüşra Çalışkan
Büşra Çalışkan
EÇEmine Çinici
Emine Çinici

1 January 2025 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
EÇEmine Çinici
Emine Çinici
MAMehmet Enes ARSLAN
Mehmet Enes ARSLAN
ÖYÖzge Çağlar Yıldırım
Özge Çağlar Yıldırım
NDNilay Dilekmen
Nilay Dilekmen
BUBAHADIR UTLU
BAHADIR UTLU
Hasan TurkezHasan Turkez
Hasan Turkez
Objective: Diabetic retinopathy (DR), considered one of the most common microvascular complications associated with diabetes mellitus (DM), involves both neuronal and vascular dysfunctions in the retina. Neuronal damage and vision loss occur progressively in patients with DR. A number of genetic targets have been identified for DR and gene-related treatments as well as early diagnostic techniques have been developed. Despite some medical advances, DR remains a devastating complication of diabetes. This study aimed to identify new gene targets that can be used for the prognosis and treatment of DR.. Materials and Methods: Eight candidate genes were analyzed using Synergy Brands Green (SYBR-green)- based real-time polymerase chain reaction in peripheral blood mononuclear cells (PBMCs) from 45 individuals: DR patients (n = 15), DM patients without DR (n = 15), and healthy controls (n = 15). STRING v11 was used for protein–protein interaction analysis. Gene expression differences were evaluated using ANOVA, with significance set at P < .05. Results: HIF1A and VEGFA were significantly upregulated in both DR and DM groups compared to controls (HIF1A: fold change 5.28; VEGFA: fold change 5.20 for DR group). SERPING1 was specifically upregulated in DR patients (fold change 3.42). CX3CR1 and BDNF were downregulated in both DR and DM groups (CX3CR1: fold change 8.32; BDNF: fold change 3.21), while IGFBP3 was significantly downregulated only in DR patients (fold change 6.5). STRING analysis revealed strong interactions between SERPING1 and complement pathway components, while IGFBP3 was linked to insulin-like growth factor signaling. Conclusion: In light of these findings, we observed that SERPING1 and IGFBP3 genes might be proposed as targets for early diagnosis and treatment for DR. Cite this article as: .inici E, Arslan ME, .ağlar Yıldırım .., et al. New gene targets for diagnosis and therapy of diabetic retinopathy. Eurasian J Med. 2025, 57(1), 0559, doi: 10.5152/eurasianjmed.2025.24559.

10 January 2026 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
BUBAHADIR UTLU
BAHADIR UTLU
EUElif Sedanur Utlu
Elif Sedanur Utlu
EÇEmine Çinici
Emine Çinici
HAHasan Akgöz
Hasan Akgöz
KBKemal Bayrakceken
Kemal Bayrakceken
BKBetül Dertsiz Kozan
Betül Dertsiz Kozan
Background: To assess macular layer thickness, macular vessel density, and foveal avascular zone (FAZ) parameters in prediabetic patients compared with healthy normoglycemic controls using optical coherence tomography angiography (OCTA). Methods: Thirty prediabetic patients (group A; fasting plasma glucose 100-125 mg/dL, postprandial plasma glucose 140-199 mg/dL, glycated hemoglobin 5.7%-6.4%) and 30 age-matched normoglycemic subjects (group B) were included. The OCTA imaging was used to evaluate superficial capillary plexus (SCP) and deep capillary plexus (DCP) vessel densities, as well as FAZ area and perimeter. Participants with poor image quality, high refractive error, glaucoma, prior intraocular surgery, chorioretinal atrophy, or other ocular/systemic comorbidities were excluded. Results: The SCP and DCP perfusion densities (PDs) were lower in the prediabetic group, with significant reductions in the inferior and temporal quadrants of the DCP and the temporal quadrant of the SCP (P < .05). The FAZ area and perimeter were larger in the prediabetic group but not statistically significant (P > .05). Macular thickness was greater in all quadrants in group A, with significant thickening in the nasal and inferior quadrants (P < .05). Conclusion: Prediabetic patients demonstrated early microvascular and structural changes, including reduced macular PD, increased macular thickness, and FAZ enlargement. These findings suggest subclinical retinal involvement in prediabetes, warranting larger longitudinal studies. Cite this article as: Utlu B, Utlu ES, Çinici E, Akgöz H, Bayrakçeken K, Kozan BD. Optical coherence tomography angiography–based evaluation of foveal avascular zone and macular vessel density in prediabetic patients. Eurasian J Med. 2026, 58 (1),1165, doi:10.5152/eurasianjmed.2026.251165.

17 November 2025 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
MYMustafa Yıldırım
Mustafa Yıldırım
EÇEmine Çinici
Emine Çinici
MÇMuhammet Çelik
Muhammet Çelik
SISelcan İçTaş
Selcan İçTaş
Background: The study aims to evaluate serum endocan (endothelial cell-specific molecule-1) levels in patients with type 2 diabetes mellitus and to determine its relationship with disease activity by comparing it with a control group. Methods: Venous blood samples were collected from 63 patients with diabetic retinopathy and healthy indi viduals who visited the policlinic between January 1, 2020, and March 1, 2020. Serum endocan and HbA1c levels were evaluated in the patients. Results: The mean age of the patient and control groups was 62 ± 10.19 and 60.27 ± 5.53, respectively. No statistically significant difference was observed between the patient and control groups in terms of age and gender. Serum endocan levels were found to be statistically significantly higher in the patient group with diabetic retinopathy (P < .05). Conclusion: It was hypothesized that serum endocan levels could serve as a guiding parameter in assessing the severity of diabetic retinopathy. Cite this article as: Yıldırım M, Çinici E, Çelik M, İçtaş S. Assessment of serum endothelial cell-specific molecule-1 (ESM-1, endocan) levels in patients with diabetic retinopathy. Eurasian J Med. 2025, 57(4), 1038, doi:10.5152/eurasianjmed.2025.251038.